Announcements

November 5, 2019

Genetics Signatures (ASX:GSS) – Appendix 3B

October 28, 2019

$A2.1m R&D Rebate Received

Company received its rebate from the Australia Tax Office for the 2019 financial year

View Announcement

October 28, 2019

Non-Executive Director Retirement

Non-executive director, Mr Phillip Isaacs, has advised he will retire from the Board t the conclusion of the 2019 Annual General Meeting

View Announcement

October 28, 2019

Genetic Signatures Ltd Completes $35m Placement

Company has raised $35m through a placement to institutional and sophisticated investors. Cornerstone investors include Perennial Value Management and Regal Funds Management plus a large global funds manager. The placement at $0.98 per share was a 9.3% discount to last closing price.

View Announcement

September 6, 2019

Genetics Signatures (ASX:GSS) – Appendix 4E & Full Year Statutory Accounts

July 25, 2019

Genetics Signatures (ASX:GSS) – Appendix 4C & Quarterly Update

June 25, 2019

Genetics Signatures (ASX:GSS) – Appendix 3B

May 27, 2019

Genetics Signatures (ASX:GSS) – TGA registration for Respiratory Pathogen Detection Kit

April 29, 2019

Genetics Signatures (ASX:GSS) – Appendix 4C & Quarterly Update

March 22, 2019

Genetics Signatures (ASX:GSS) -Change of Director’s Interest Notice